Study of genetically modified mice has contributed to our understanding of the susceptibility to AD and other neurodegenerative diseases conferred by mutations or variants in APP, APOE, and related genes (Di Battista et al. 2016). This evidence concerns the gene APP and neurodegenerative disease.